MCM
GSK icon

Monument Capital Management’s GSK GSK Stock Holding History

Monument Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Hold
5,257
– – 0.06% 217
2026
Q1 		$290K Buy
5,257
+152
+3% +$8.24K 0.07% 182
2025
Q4 		$250K Buy
5,105
+467
+10% +$21.8K 0.06% 192
2025
Q3 		$200K Buy
+4,638
New +$181K 0.05% 219

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Monument Capital Management's GSK Position: Q2 2026 in Review

Monument Capital Management held its GSK (GSK) position steady in Q2 2026 at 5,257 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #217.

Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $290K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Monument Capital Management held 5,257 shares of GSK worth $276K as of Q2 2026.
  • Monument Capital Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.06% of Monument Capital Management's portfolio in Q2 2026, its #217 holding.
  • Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Monument Capital Management's GSK position peaked at $290K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.